Quick Answer
CASTLE BIOSCIENCES INC reported Diluted EPS of $0.83 per share (loss) for fiscal year 2025.
CASTLE BIOSCIENCES INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.83 | -233.9% |
| 2024 | $0.62 | +129.0% |
| 2023 | -$2.14 | +17.1% |
| 2022 | -$2.58 | -108.1% |
| 2021 | -$1.24 | -129.6% |
| 2020 | -$0.54 | -157.1% |
| 2019 | -$0.21 | +96.1% |
| 2018 | -$5.33 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | -125.0% | -113.3% |
| June 30, 2025 | $0.15 | -51.6% | +116.7% |
| March 31, 2025 | -$0.90 | -900.0% | -1225.0% |
| September 30, 2024 | $0.08 | +130.8% | -74.2% |
| June 30, 2024 | $0.31 | +144.3% | +444.4% |
| March 31, 2024 | -$0.09 | +91.8% | +65.4% |
| September 30, 2023 | -$0.26 | +66.2% | +62.9% |
| June 30, 2023 | -$0.70 | -1066.7% | +36.4% |
- CASTLE BIOSCIENCES INC showed a decrease of -233.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, CASTLE BIOSCIENCES INC’s diluted eps has grown by 84.4% (from $5.33 per share (loss) to $0.83 per share (loss)).
- The most recent figure is from CASTLE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: